Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Anthony S. Wierzbicki, Scott D. Purdon, Timothy C. Hardman, Ranjababu Kulasegaram & Barry S. Peters. (2008) HIV lipodystrophy and its metabolic consequences: implications for clinical practice. Current Medical Research and Opinion 24:3, pages 609-624.
Read now
Read now
Steen B Haugaard. (2006) Toxic metabolic syndrome associated with HAART. Expert Opinion on Drug Metabolism & Toxicology 2:3, pages 429-445.
Read now
Read now
Articles from other publishers (21)
E. L. Sorkina, V. V. Chichkova, I. A. Sklyanik, M. V. Shestakova, G. A. Mel'nichenko & A. Barkan. (2021) The role of glucose and insulin in the metabolic regulation of growth hormone secretion. Problems of Endocrinology 67:1, pages 52-59.
Crossref
Crossref
Amy Y.‐Y. Chen & Amit Garg. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition
1
36
.
Josephine Pui-Hing Wong, Alan Tai-Wai Li, Maurice Kwong-Lai Poon & Kenneth Po-Lun Fung. (2013) An exploratory study on the mental health of immigrants, refugees and non-status people living with HIV in Toronto. International Journal of Migration, Health and Social Care 9:3, pages 122-134.
Crossref
Crossref
Esteban Martínez. (2011) Disorders of fat partitioning in treated HIV–infection. Best Practice & Research Clinical Endocrinology & Metabolism 25:3, pages 415-427.
Crossref
Crossref
Siddharth H Sheth & Robin J Larson. (2010) The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials. BMC Infectious Diseases 10:1.
Crossref
Crossref
Carl Grunfeld, Michael Saag, Joseph Cofrancesco, Cora Elizabeth Lewis, Richard Kronmal, Steven Heymsfield, Phyllis C Tien, Peter Bacchetti, Michael Shlipak & Rebecca Scherzer. (2010) Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy. AIDS 24:11, pages 1717-1726.
Crossref
Crossref
BR Hansen, J Petersen, SB Haugaard, S Madsbad, N Obel, Y Suzuki & O Andersen. (2009) The prevalence of metabolic syndrome in Danish patients with HIV infection: the effect of antiretroviral therapy. HIV Medicine 10:6, pages 378-387.
Crossref
Crossref
Jussi Sutinen. (2009) The Effects of Thiazolidinediones on Metabolic Complications and Lipodystrophy in HIV-Infected Patients. PPAR Research 2009, pages 1-15.
Crossref
Crossref
Joseph CofrancescoJr.Jr., Eric FreedlandGrace McComsey. (2009) Treatment Options for HIV-Associated Central Fat Accumulation. AIDS Patient Care and STDs 23:1, pages 5-18.
Crossref
Crossref
Raphael J. Landovitz, Jonathan B. Angel, Christian Hoffmann, Heinz Horst, Milos Opravil, Jianmin Long, Wayne Greaves & Gerd Fätkenheuer. (2008) Phase II Study of Vicriviroc versus Efavirenz (both with Zidovudine/Lamivudine) in Treatment‐Naive Subjects with HIV‐1 Infection. The Journal of Infectious Diseases 198:8, pages 1113-1122.
Crossref
Crossref
R. A. Bradbury & K. Samaras. (2008) Antiretroviral therapy and the human immunodeficiency virus – improved survival but at what cost?. Diabetes, Obesity and Metabolism 10:6, pages 441-450.
Crossref
Crossref
Rebeca Goiriz & Jesús Fernández Herrera. (2008) Toxicodermias en pacientes con síndrome de inmunodeficiencia adquirida. Piel 23:6, pages 303-308.
Crossref
Crossref
W. Todd Cade. (2008) Left Ventricular Dysfunction in Human Immunodeficiency Virus Infection. Journal of the CardioMetabolic Syndrome 3:2, pages 83-87.
Crossref
Crossref
Julian Falutz. (2007) Therapy Insight: body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy. Nature Clinical Practice Endocrinology & Metabolism 3:9, pages 651-661.
Crossref
Crossref
Etai Funk, Anthony E. Brissett, Craig D. Friedman & Fred J. Bressler. (2009) HIV‐Associated Facial Lipoatrophy: Establishment of a Validated Grading Scale. The Laryngoscope 117:8, pages 1349-1353.
Crossref
Crossref
Emma Hammond & David Nolan. (2007) Adipose tissue inflammation and altered adipokine and cytokine production in antiretroviral therapy-associated lipodystrophy. Current Opinion in HIV and AIDS 2:4, pages 274-281.
Crossref
Crossref
J. Ockenga, R. Grimble, C. Jonkers-Schuitema, D. Macallan, J.-C. Melchior, H.P. Sauerwein, A. Schwenk & U. Süttmann. (2006) ESPEN Guidelines on Enteral Nutrition: Wasting in HIV and other chronic infectious diseases. Clinical Nutrition 25:2, pages 319-329.
Crossref
Crossref
Lisa A Kosmiski, Heidi L Miller & Dwight J Klemm. (2005) In Combination, Nucleoside Reverse Transcriptase Inhibitors Have Significant Effects on 3T3–L1 Adipocyte Lipid Accumulation and Survival. Antiviral Therapy 11:2, pages 187-196.
Crossref
Crossref
Alessandra Viganò, Grace M Aldrovandi, Vania Giacomet, Marzia Merlo, Laura Martelli, Silvia Beretta, Paola Luraschi, Giuseppe Rombolà & Stefano Mora. (2005) Improvement in Dyslipidaemia after Switching Stavudine to Tenofovir and Replacing Protease Inhibitors with Efavirenz in HIV-Infected Children. Antiviral Therapy 10:8, pages 917-924.
Crossref
Crossref
Jussi Sutinen. (2005) Interventions for managing antiretroviral therapy-associated lipoatrophy. Current Opinion in Infectious Diseases 18:1, pages 25-33.
Crossref
Crossref
Dan Streja. (2004) Metabolic syndrome and other factors associated with increased risk of diabetes. Clinical Cornerstone 6:3, pages S14-S29.
Crossref
Crossref